Toward Optimal Dosing in Systemic Lupus Erythematosus: The Case for Hydroxychloroquine Blood Level Monitoring.
Publication
, Journal Article
Balevic, S; Thomas, D; Garg, S
Published in: Arthritis Care Res (Hoboken)
February 16, 2026
Duke Scholars
Published In
Arthritis Care Res (Hoboken)
DOI
EISSN
2151-4658
Publication Date
February 16, 2026
Location
United States
Related Subject Headings
- 4201 Allied health and rehabilitation science
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Balevic, S., Thomas, D., & Garg, S. (2026). Toward Optimal Dosing in Systemic Lupus Erythematosus: The Case for Hydroxychloroquine Blood Level Monitoring. Arthritis Care Res (Hoboken). https://doi.org/10.1002/acr.80020
Balevic, Stephen, Donald Thomas, and Shivani Garg. “Toward Optimal Dosing in Systemic Lupus Erythematosus: The Case for Hydroxychloroquine Blood Level Monitoring.” Arthritis Care Res (Hoboken), February 16, 2026. https://doi.org/10.1002/acr.80020.
Balevic S, Thomas D, Garg S. Toward Optimal Dosing in Systemic Lupus Erythematosus: The Case for Hydroxychloroquine Blood Level Monitoring. Arthritis Care Res (Hoboken). 2026 Feb 16;
Balevic, Stephen, et al. “Toward Optimal Dosing in Systemic Lupus Erythematosus: The Case for Hydroxychloroquine Blood Level Monitoring.” Arthritis Care Res (Hoboken), Feb. 2026. Pubmed, doi:10.1002/acr.80020.
Balevic S, Thomas D, Garg S. Toward Optimal Dosing in Systemic Lupus Erythematosus: The Case for Hydroxychloroquine Blood Level Monitoring. Arthritis Care Res (Hoboken). 2026 Feb 16;
Published In
Arthritis Care Res (Hoboken)
DOI
EISSN
2151-4658
Publication Date
February 16, 2026
Location
United States
Related Subject Headings
- 4201 Allied health and rehabilitation science
- 3202 Clinical sciences